Simple breathing device may strengthen core and cut liver fat in seniors

NCT ID NCT07168733

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a 4-week program of inspiratory muscle training (using a device called POWERbreathe) could improve diaphragm and abdominal wall muscle thickness and reduce liver fat in healthy women aged 60-80. Twenty-six women were split into a training group and a control group. The training group did breathing exercises twice daily, five days a week. Researchers measured muscle thickness and liver fat before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Inspiratory muscle training using the POWERbreathe® device
What this could lead to
If successful, this could point toward a simple, drug-free way to help older women maintain muscle strength and reduce liver fat.
What could go wrong
This is a very small, early study with only 26 participants, so results may not apply to everyone. The training lasted only 4 weeks, so long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Jun 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 80 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * were defined as women aged 60-80 years (post-menopausal), who were independent in activities of daily living, * demonstrated adequate cognitive function to follow instructions, * had no musculoskeletal injury within the previous six months, * were non-smokers, * had routine thoracic or abdominal CT images obtained for clinical indications and used in this study. Exclusion Criteria: * included having uncontrolled cardiovascular or pulmonary disease such as heart failure or COPD/asthma exacerbation, * uncontrolled hypertension, diagnosed chronic liver disease, * acute respiratory infection within the last four weeks, * participation in structured respiratory or resistance training within the last six months, * recent thoracoabdominal surgery or hernia, use of medications known to affect muscle or liver metabolism such as systemic corticosteroids, anabolic agents, or hepatotoxic drugs, * severe orthopedic or neurological conditions limiting mobility, or refusal to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perceived recovery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gumushane Univetsity

    Kelkit, Gümüşhane Province, 29600, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.